CN112142839A - A method suitable for industrial large-scale extraction of egg yolk antibodies - Google Patents
A method suitable for industrial large-scale extraction of egg yolk antibodies Download PDFInfo
- Publication number
- CN112142839A CN112142839A CN202011203157.6A CN202011203157A CN112142839A CN 112142839 A CN112142839 A CN 112142839A CN 202011203157 A CN202011203157 A CN 202011203157A CN 112142839 A CN112142839 A CN 112142839A
- Authority
- CN
- China
- Prior art keywords
- egg yolk
- yolk antibody
- extraction
- supernatant
- egg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000002969 egg yolk Anatomy 0.000 title claims abstract description 216
- 102000002322 Egg Proteins Human genes 0.000 title claims abstract description 201
- 108010000912 Egg Proteins Proteins 0.000 title claims abstract description 201
- 235000013345 egg yolk Nutrition 0.000 title claims abstract description 163
- 238000000034 method Methods 0.000 title claims abstract description 36
- 238000000605 extraction Methods 0.000 title claims description 42
- 239000006228 supernatant Substances 0.000 claims abstract description 52
- 239000000243 solution Substances 0.000 claims abstract description 46
- 239000011536 extraction buffer Substances 0.000 claims abstract description 34
- 238000003756 stirring Methods 0.000 claims abstract description 26
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 25
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 25
- 239000007974 sodium acetate buffer Substances 0.000 claims abstract description 21
- BHZOKUMUHVTPBX-UHFFFAOYSA-M sodium acetic acid acetate Chemical compound [Na+].CC(O)=O.CC([O-])=O BHZOKUMUHVTPBX-UHFFFAOYSA-M 0.000 claims abstract description 21
- 239000007788 liquid Substances 0.000 claims abstract description 19
- 239000002244 precipitate Substances 0.000 claims abstract description 15
- 229910021392 nanocarbon Inorganic materials 0.000 claims abstract description 6
- 230000001954 sterilising effect Effects 0.000 claims abstract description 3
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 claims description 62
- 235000013601 eggs Nutrition 0.000 claims description 48
- 239000000284 extract Substances 0.000 claims description 33
- 238000001556 precipitation Methods 0.000 claims description 20
- 239000002086 nanomaterial Substances 0.000 claims description 16
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 8
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 4
- 229930003268 Vitamin C Natural products 0.000 claims description 4
- 235000019154 vitamin C Nutrition 0.000 claims description 4
- 239000011718 vitamin C Substances 0.000 claims description 4
- 238000002848 electrochemical method Methods 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 claims description 2
- 239000002105 nanoparticle Substances 0.000 claims 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 abstract description 25
- 210000000969 egg white Anatomy 0.000 abstract description 25
- 235000014103 egg white Nutrition 0.000 abstract description 25
- 239000000203 mixture Substances 0.000 abstract 1
- 230000001376 precipitating effect Effects 0.000 abstract 1
- 238000005406 washing Methods 0.000 abstract 1
- OSVXSBDYLRYLIG-UHFFFAOYSA-N dioxidochlorine(.) Chemical compound O=Cl=O OSVXSBDYLRYLIG-UHFFFAOYSA-N 0.000 description 24
- 239000008399 tap water Substances 0.000 description 24
- 235000020679 tap water Nutrition 0.000 description 24
- 230000000694 effects Effects 0.000 description 16
- 208000032843 Hemorrhage Diseases 0.000 description 14
- 241000700605 Viruses Species 0.000 description 13
- 239000004155 Chlorine dioxide Substances 0.000 description 12
- 241001315730 Cyprinid herpesvirus 2 Species 0.000 description 12
- 239000007864 aqueous solution Substances 0.000 description 12
- 239000000872 buffer Substances 0.000 description 12
- 235000019398 chlorine dioxide Nutrition 0.000 description 12
- 239000000645 desinfectant Substances 0.000 description 12
- 210000003278 egg shell Anatomy 0.000 description 12
- 239000007853 buffer solution Substances 0.000 description 11
- 241001609213 Carassius carassius Species 0.000 description 10
- 108090000623 proteins and genes Proteins 0.000 description 9
- 239000002202 Polyethylene glycol Substances 0.000 description 8
- 229920001223 polyethylene glycol Polymers 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 230000001580 bacterial effect Effects 0.000 description 7
- 239000007921 spray Substances 0.000 description 6
- 238000002965 ELISA Methods 0.000 description 5
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 5
- 241000252233 Cyprinus carpio Species 0.000 description 4
- 241000157468 Reinhardtius hippoglossoides Species 0.000 description 4
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 4
- 235000011130 ammonium sulphate Nutrition 0.000 description 4
- 239000000287 crude extract Substances 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 238000007792 addition Methods 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- 238000003809 water extraction Methods 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 108060003951 Immunoglobulin Proteins 0.000 description 2
- 102000004895 Lipoproteins Human genes 0.000 description 2
- 108090001030 Lipoproteins Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 2
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- 238000002983 circular dichroism Methods 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 102000018358 immunoglobulin Human genes 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000012474 protein marker Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- 101000768120 Oryza nivara Uncharacterized protein ycf76 Proteins 0.000 description 1
- 101000708297 Pseudomonas stutzeri Uncharacterized 8.5 kDa protein in nirQ 3'region Proteins 0.000 description 1
- 101000768117 Saccharum officinarum Uncharacterized protein ycf70 Proteins 0.000 description 1
- 101000953979 Streptomyces lividans Uncharacterized 6.6 kDa protein Proteins 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- 238000003453 ammonium sulfate precipitation method Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 210000000991 chicken egg Anatomy 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000005238 degreasing Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000017525 heat dissipation Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000000751 protein extraction Methods 0.000 description 1
- 230000006920 protein precipitation Effects 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/02—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from eggs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/145—Extraction; Separation; Purification by extraction or solubilisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/30—Extraction; Separation; Purification by precipitation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
- C07K16/245—IL-1
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Virology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
技术领域technical field
本发明涉及一种卵黄抗体提取方法,尤其是涉及一种适用于工业化大规模提取卵黄抗体的方法。The invention relates to a method for extracting egg yolk antibodies, in particular to a method suitable for industrial large-scale extraction of egg yolk antibodies.
背景技术Background technique
卵黄抗体又称卵黄免疫球蛋白(egg yolk immunoglobulin,IgY),是鸡血清IgG转移到卵黄中形成的特异性抗体,具有类似哺乳动物IgG的免疫活性,但与哺乳动物IgG相比,IgY有更好的化学稳定性,产量高、制备简单、成本低、绿色安全等优点,并在食品、医药、生物品等方面得到了广泛应用。Egg yolk antibody, also known as egg yolk immunoglobulin (egg yolk immunoglobulin, IgY), is a specific antibody formed by the transfer of chicken serum IgG into egg yolk, and has the same immunological activity as mammalian IgG, but compared with mammalian IgG, IgY has more It has the advantages of good chemical stability, high yield, simple preparation, low cost, green safety, etc., and has been widely used in food, medicine, biological products, etc.
鸡卵黄中含48%左右的水份、17%左右的蛋白质和30%左右的脂肪,脂肪易与蛋白质结合形成脂蛋白,其中卵黄抗体属于可溶性卵黄蛋白。目前卵黄抗体提取的方法有很多种,常见的方法有:1、聚乙二醇(PEG)沉淀法,此法是目前规模化提取卵黄抗体较常用的方法。其优点是PEG是非离子型水溶性多聚体的有机溶剂,易溶于水,散热低,形成蛋白沉淀的时间短。但PEG属于有机溶剂,目前暂无办法去除提取液中的PEG,残留的PEG对养殖动物是否存在危害尚无定论,同时PEG价格高用量大,会增加很多成本。2、硫酸铵沉淀法。此法优点是对设备和条件要求低,硫酸铵价格低廉,性质温和。缺点是硫酸铵用量太大,且缓冲能力差,对卵黄抗体活性有影响,且大量硫酸铵的废液造成环境污染。3、辛酸或氯仿等有机溶剂提取法。此方法中的有机溶剂不仅影响抗体活性,且有毒、污染环境。4、酸化水提取法,其原理是在酸性pH和低浓度的离子环境中,卵黄中的脂蛋白凝聚而析出,达到分离提取卵黄抗体的目的。此法卵黄抗体损耗较大。另外酸化水稳定系统差,且存在提取后的卵黄抗体保质期较短的问题。因此,探索工艺简单、去脂效果好、成本低,抗体稳定,环境友好的卵黄抗体提纯方法,是本领域技术人员需要突破的技术难点。Chicken egg yolk contains about 48% water, about 17% protein and about 30% fat. Fat is easy to combine with protein to form lipoprotein, and egg yolk antibody belongs to soluble egg yolk protein. At present, there are many methods for extracting egg yolk antibody, and the common methods are: 1. Polyethylene glycol (PEG) precipitation method, which is the most commonly used method for large-scale extraction of egg yolk antibody. The advantage is that PEG is an organic solvent for non-ionic water-soluble polymers, easily soluble in water, low in heat dissipation, and short in time to form protein precipitation. However, PEG is an organic solvent. At present, there is no way to remove PEG in the extract. Whether the residual PEG is harmful to farmed animals is still inconclusive. At the same time, the high price of PEG and the large amount of PEG will increase a lot of costs. 2. Ammonium sulfate precipitation method. The advantages of this method are that it has low requirements on equipment and conditions, low price of ammonium sulfate, and mild properties. The disadvantage is that the amount of ammonium sulfate is too large, and the buffering capacity is poor, which has an impact on the activity of the yolk antibody, and the waste liquid of a large amount of ammonium sulfate causes environmental pollution. 3. Organic solvent extraction method such as octanoic acid or chloroform. The organic solvent in this method not only affects the activity of the antibody, but also is toxic and pollutes the environment. 4. The acidified water extraction method, the principle is that in the acidic pH and low-concentration ion environment, the lipoproteins in the egg yolk aggregate and separate out, so as to achieve the purpose of separating and extracting the egg yolk antibody. This method has a large loss of yolk antibody. In addition, the acidified water stability system is poor, and the shelf life of the extracted egg yolk antibody is short. Therefore, it is a technical difficulty that those skilled in the art need to break through to explore a method for purifying egg yolk antibody with simple process, good degreasing effect, low cost, stable antibody and environmental friendliness.
发明内容SUMMARY OF THE INVENTION
本发明所要解决的技术问题是提供一种提取率高、稳定性好、无污染且具有高效抑菌作用的适用于工业化大规模提取卵黄抗体的方法。The technical problem to be solved by the present invention is to provide a method suitable for industrialized large-scale extraction of egg yolk antibody with high extraction rate, good stability, no pollution and high-efficiency bacteriostatic effect.
本发明解决上述技术问题所采用的技术方案为:一种适用于工业化大规模提取卵黄抗体的方法,其特征在于包括以下步骤:The technical scheme adopted by the present invention to solve the above-mentioned technical problems is: a method suitable for industrialized large-scale extraction of egg yolk antibody, which is characterized by comprising the following steps:
(1)将高免蛋清洗消毒后分离得卵黄,搅拌均匀,制得卵黄液;(1) separating the egg yolk after cleaning and sterilizing the high-free egg, stirring evenly to obtain egg yolk liquid;
(2)将一种纳米碳点加入pH值为5.0~5.2的乙酸-乙酸钠缓冲溶液中,制成含碳点的卵黄抗体提取缓冲液;(2) adding a kind of nano carbon dots to an acetic acid-sodium acetate buffer solution with a pH value of 5.0-5.2 to prepare a carbon dot-containing egg yolk antibody extraction buffer;
(3)将卵黄液加入到卵黄抗体提取缓冲液中,搅拌均匀,室温静置沉淀取上清,再将沉淀经离心得上清液,合并两次所得上清液,即为卵黄抗体提取液。(3) Add the egg yolk solution to the egg yolk antibody extraction buffer, stir evenly, let the precipitation stand at room temperature to get the supernatant, then centrifuge the precipitation to obtain the supernatant, and combine the supernatants obtained twice to obtain the egg yolk antibody extract .
进一步,步骤(1)中搅拌转速为50~500r/min,时间为10~20min。Further, in step (1), the stirring speed is 50-500 r/min, and the time is 10-20 min.
进一步,步骤(2)中乙酸-乙酸钠缓冲溶液中纳米碳点浓度为5~25μg/ml。Further, in step (2), the concentration of nano carbon dots in the acetic acid-sodium acetate buffer solution is 5-25 μg/ml.
进一步,所述的纳米碳点为将维生素C通过一步法电化学方法制备所得的尺寸在50nm以下的零维碳基纳米材料。Further, the carbon nanodots are zero-dimensional carbon-based nanomaterials with a size below 50 nm obtained by preparing vitamin C by a one-step electrochemical method.
进一步,步骤(2)中所述的乙酸-乙酸钠缓冲溶液的浓度为0.1~0.5M,pH值为5.0~5.2。Further, the concentration of the acetic acid-sodium acetate buffer solution described in step (2) is 0.1-0.5M, and the pH value is 5.0-5.2.
进一步,步骤(3)中所述的卵黄液与所述的卵黄抗体提取缓冲液的质量体积比为1:(5~10)。Further, the mass-volume ratio of the egg yolk solution described in step (3) and the egg-yolk antibody extraction buffer is 1: (5-10).
进一步,步骤(3)具体过程为:将卵黄液按质量体积比1:(5~10)的比例加入到卵黄抗体提取缓冲液中,50~500r/min搅拌10~20min,室温静置沉淀8~15h;吸取上清后,再将沉淀经4000~12000r/min离心10~30min取上清液,合并两次所得上清液,即为卵黄抗体提取液。Further, the specific process of step (3) is as follows: adding the egg yolk solution to the egg yolk antibody extraction buffer at a ratio of 1: (5-10) by mass, stirring at 50-500 r/min for 10-20 min, and leaving it to settle at room temperature for 8 ~15h; after aspirating the supernatant, centrifuge the precipitate at 4000-12000 r/min for 10-30 min to take the supernatant, and combine the supernatants obtained twice to obtain the egg yolk antibody extract.
与现有技术相比,本发明的优点在于:Compared with the prior art, the advantages of the present invention are:
1)与传统的酸化水提取方法相比,本发明在缓冲体系中添加了可分解无残留的用维生素C制备的碳点,进一步提高了IgY的得率,所得IgY稳定性好。解决了现有技术中提取卵黄抗体方法中存在成本大、抗体损耗大的问题。1) Compared with the traditional acidified water extraction method, the present invention adds decomposable and residue-free carbon dots prepared with vitamin C in the buffer system, further improving the yield of IgY, and the obtained IgY has good stability. The problems of high cost and large loss of antibodies in the method for extracting egg yolk antibodies in the prior art are solved.
2)因碳点具很强的抑菌作用特点,卵黄抗体提取过程可在室温进行。因此,与传统的提取方法需在4℃下沉淀过夜相比,本发明设备要求简单,操作简便。同时,因碳点在空气中可见光下可以完全降解为CO2、CO和H2O而无毒性,所以沉淀物还可开发为食品或饲料原料,提高利用率,实现零污染。2) Due to the strong antibacterial effect of carbon dots, the extraction process of egg yolk antibody can be carried out at room temperature. Therefore, compared with the traditional extraction method, which requires overnight precipitation at 4° C., the device of the present invention has simple requirements and is easy to operate. At the same time, because carbon dots can be completely degraded into CO 2 , CO and H 2 O under visible light in the air without toxicity, the sediment can also be developed into food or feed raw materials to improve the utilization rate and achieve zero pollution.
3)与传统的酸化水提取方法相比,本发明采用“0.1M~0.5M乙酸-乙酸钠缓冲溶液”,使得IgY在缓冲体系中活性稳定。3) Compared with the traditional acidified water extraction method, the present invention adopts "0.1M-0.5M acetic acid-sodium acetate buffer solution", so that the activity of IgY is stable in the buffer system.
4)本发明采用的碳点提取工艺结束后,在自然光线下20d左右完全降解为CO2、CO和H2O,无残留,绿色安全。解决了常规方法中提取液中残留的有机物及高剂量防腐剂对动物或人体存在潜在风险的技术问题。4) After the carbon dot extraction process adopted in the present invention is completed, it is completely degraded into CO 2 , CO and H 2 O under natural light for about 20 days, with no residue, and is green and safe. The technical problem of potential risks to animals or humans caused by residual organic matter and high-dose preservatives in the extraction solution in the conventional method is solved.
综上所述,本发明提供了一种适用于工业化大规模提取卵黄抗体的方法,该方法步骤简单、成本低、高效;添加的纳米碳点具有高效抑菌作用,在提高卵黄抗体得率的同时,避免了传统酸化水提取卵黄抗体时需4℃低温过夜沉淀的缺点,不加或少加防腐剂,绿色无污染。To sum up, the present invention provides a method suitable for industrial large-scale extraction of egg yolk antibody, the method has simple steps, low cost and high efficiency; the added nano-carbon dots have high bacteriostatic effect, which can improve the yield of egg yolk antibody. At the same time, it avoids the disadvantage of overnight precipitation at a low temperature of 4°C when extracting egg yolk antibodies with traditional acidified water. No or less preservatives are added, and the product is green and pollution-free.
附图说明Description of drawings
图1为圆二色谱分析不同浓度碳点对IgY结构影响的结果;Fig. 1 is the result of circular dichroism analysis of the effect of different concentrations of carbon dots on the structure of IgY;
图2为经19wt%硫酸铵溶液一次沉淀后的不同浓度碳点及不同比例缓冲液提取的卵黄抗体SDS-PAGE电泳初步检测IgY得率。其中:M为蛋白Marker,泳道1~3分别为碳点浓度为0μg/mL,泳道4~6分别为碳点浓度为6.25μg/mL,泳道7~9分别为碳点浓度为12.5μg/mL,泳道10~12分别为碳点浓度为25μg/mL;同时,泳道1、4、7、10还表示卵黄与缓冲液质量体积比为1:5,泳道2、5、8、11还表示卵黄与缓冲液质量体积比为1:7,泳道3、6、9、12还表示卵黄与缓冲液质量体积比为1:9;Figure 2 is the preliminary detection of IgY yields by SDS-PAGE electrophoresis of egg yolk antibodies extracted from Cdots of different concentrations and buffers of different proportions after precipitation with 19wt% ammonium sulfate solution. Among them: M is the protein marker,
图3为ELISA法测定抗大菱鲆IL-1β卵黄抗体提取液中抗体效价的结果;Fig. 3 is the result of measuring antibody titer in anti-Turbot IL-1β egg yolk antibody extract by ELISA method;
图4为ELISA法测定抗鲫鱼鳃出血病病毒(CyHV-2)卵黄抗体提取液中抗体效价的结果;Fig. 4 is the result that ELISA method measures the antibody titer in anti-crucian carp gill hemorrhage virus (CyHV-2) yolk antibody extract;
图5为抗鲫鱼鳃出血病病毒(CyHV-2)卵黄与缓冲液质量体积比为1:9,不同浓度碳点提取的卵黄抗体在4℃和室温条件下静置沉淀15h后粗提液中的总菌数。Figure 5 shows that the mass-to-volume ratio of yolk against crucian carp gill hemorrhage virus (CyHV-2) to the buffer is 1:9, and the yolk antibodies extracted from carbon dots with different concentrations were left for 15h at 4°C and room temperature. total bacterial count.
具体实施方式Detailed ways
以下结合附图实施例对本发明作进一步详细描述。The present invention will be further described in detail below with reference to the embodiments of the accompanying drawings.
一、具体实施例1. Specific Examples
实施例1Example 1
抗大菱鲆IL-1β卵黄抗体的提取Extraction of Anti-Turbot IL-1β Egg Yolk Antibody
1、抗大菱鲆IL-1β高免蛋用常温自来水清洗1min,用0.25mg/L的二氧化氯水溶液消毒洗净的鸡蛋1min;再用自来水喷淋消毒过的鸡蛋2min,去除消毒液,将洗净的鸡蛋送入蛋清蛋黄分离机,分离蛋壳、蛋清及蛋黄,收集卵黄,称重,100r/min搅拌10min,得卵黄液,待用;1. Anti-Turbot IL-1β high-immunity eggs were washed with tap water at room temperature for 1 min, and the washed eggs were disinfected with 0.25mg/L chlorine dioxide aqueous solution for 1 min; then spray the sterilized eggs with tap water for 2 min, remove the disinfectant, The washed eggs are sent to the egg white and yolk separator, the egg shell, egg white and egg yolk are separated, the egg yolk is collected, weighed, and stirred at 100 r/min for 10 minutes to obtain egg yolk liquid, which is ready for use;
2、将新型零维碳基纳米材料碳点加入到浓度为0.1M,pH值5.1的乙酸-乙酸钠缓冲溶液中,制成含碳点浓度为6.25μg/mL的卵黄抗体提取缓冲液;2. Add the new zero-dimensional carbon-based nanomaterial carbon dots into the acetic acid-sodium acetate buffer solution with a concentration of 0.1M and a pH value of 5.1 to prepare a yolk antibody extraction buffer containing carbon dots with a concentration of 6.25 μg/mL;
3、按质量体积比为1:5的比例在卵黄液中加入卵黄抗体提取缓冲液,100r/min搅3. Add egg yolk antibody extraction buffer to the egg yolk solution at a ratio of 1:5 by mass to volume, stir at 100 r/min
拌20min,室温静置沉淀8h;用真空泵吸取上清至的洁净容器,沉淀再12000r/min离心20min取上清,合并上清液即得到卵黄抗体提取液。Stir for 20 min, and settle for 8 h at room temperature; suck the supernatant into a clean container with a vacuum pump, and then centrifuge the supernatant at 12,000 r/min for 20 min to take the supernatant, and combine the supernatant to obtain the egg yolk antibody extract.
实施例2Example 2
抗大菱鲆IL-1β卵黄抗体的提取Extraction of Anti-Turbot IL-1β Egg Yolk Antibody
1、抗大菱鲆IL-1β高免蛋用常温自来水清洗1min,用0.25mg/L的二氧化氯水溶液消毒洗净的鸡蛋1min;再用自来水喷淋消毒过的鸡蛋2min,去除消毒液,将洗净的鸡蛋送入蛋清蛋黄分离机,分离蛋壳、蛋清及蛋黄,收集卵黄,称重,200r/min搅拌10min,得卵黄液,待用;1. Anti-Turbot IL-1β high-immunity eggs were washed with tap water at room temperature for 1 min, and the washed eggs were disinfected with 0.25mg/L chlorine dioxide aqueous solution for 1 min; then spray the sterilized eggs with tap water for 2 min, remove the disinfectant, The washed eggs are sent to the egg white and yolk separator to separate the egg shell, egg white and egg yolk, collect the yolk, weigh, stir at 200 r/min for 10 min to obtain egg yolk liquid, which is ready for use;
2、将新型零维碳基纳米材料碳点加入到浓度为0.2M,pH值5.1的乙酸-乙酸钠缓冲溶液中,制成含碳点浓度为6.25μg/mL的卵黄抗体提取缓冲液;2. Add the new zero-dimensional carbon-based nanomaterial carbon dots into the acetic acid-sodium acetate buffer solution with a concentration of 0.2M and a pH value of 5.1 to prepare a yolk antibody extraction buffer containing carbon dots with a concentration of 6.25 μg/mL;
3、按质量体积比为1:7的比例在卵黄液中加入卵黄抗体提取缓冲液,200r/min搅拌20min,室温静置沉淀12h;用真空泵吸取上清至的洁净容器,沉淀再8000r/min离心30min取上清,合并上清液即得到卵黄抗体提取液。3. Add egg yolk antibody extraction buffer to the egg yolk solution at a ratio of 1:7 by mass to volume, stir at 200 r/min for 20 minutes, and let it stand for 12 hours at room temperature for precipitation; use a vacuum pump to suck the supernatant into a clean container, and then precipitate at 8000 r/min. Centrifuge for 30 min to take the supernatant, and combine the supernatant to obtain the egg yolk antibody extract.
实施例3Example 3
抗大菱鲆IL-1β卵黄抗体的提取Extraction of Anti-Turbot IL-1β Egg Yolk Antibody
1、抗大菱鲆IL-1β高免蛋用常温自来水清洗1min,用0.25mg/L的二氧化氯水溶液消毒洗净的鸡蛋1min;再用自来水喷淋消毒过的鸡蛋2min,去除消毒液,将洗净的鸡蛋送入蛋清蛋黄分离机,分离蛋壳、蛋清及蛋黄,收集卵黄,称重,300r/min搅拌10min,得卵黄液,待用;1. Anti-Turbot IL-1β high-immunity eggs were washed with tap water at room temperature for 1 min, and the washed eggs were disinfected with 0.25mg/L chlorine dioxide aqueous solution for 1 min; then spray the sterilized eggs with tap water for 2 min, remove the disinfectant, The washed eggs are sent to the egg white and yolk separator, the egg shell, egg white and egg yolk are separated, the egg yolk is collected, weighed, and stirred at 300 r/min for 10 minutes to obtain egg yolk liquid, which is ready for use;
2、将新型零维碳基纳米材料碳点加入到浓度为0.3M,pH值5.1的乙酸-乙酸钠缓冲溶液中,制成含碳点浓度为6.25μg/mL的卵黄抗体提取缓冲液;2. Add the new zero-dimensional carbon-based nanomaterial carbon dots into an acetic acid-sodium acetate buffer solution with a concentration of 0.3M and a pH value of 5.1 to prepare a yolk antibody extraction buffer containing carbon dots with a concentration of 6.25 μg/mL;
3、按质量体积比为1:9的比例在卵黄液中加入卵黄抗体提取缓冲液,500r/min搅拌10min,室温静置沉淀15h;用真空泵吸取上清至的洁净容器,沉淀再5000r/min离心30min取上清,合并上清液即得到卵黄抗体提取液。3. Add egg yolk antibody extraction buffer to the egg yolk solution at a ratio of 1:9 by mass to volume, stir at 500 r/min for 10 minutes, and let it stand for 15 hours at room temperature for precipitation; use a vacuum pump to suck the supernatant into a clean container, and then precipitate at 5000 r/min. Centrifuge for 30 min to take the supernatant, and combine the supernatant to obtain the egg yolk antibody extract.
实施例4Example 4
抗大菱鲆IL-1β卵黄抗体的提取Extraction of Anti-Turbot IL-1β Egg Yolk Antibody
1、抗大菱鲆IL-1β高免蛋用常温自来水清洗1min,用0.25mg/L的二氧化氯水溶液消毒洗净的鸡蛋1min;再用自来水喷淋消毒过的鸡蛋2min,去除消毒液,将洗净的鸡蛋送入蛋清蛋黄分离机,分离蛋壳、蛋清及蛋黄,收集卵黄,称重,300r/min搅拌10min,得卵黄液,待用;1. Anti-Turbot IL-1β high-immunity eggs were washed with tap water at room temperature for 1 min, and the washed eggs were disinfected with 0.25mg/L chlorine dioxide aqueous solution for 1 min; then spray the sterilized eggs with tap water for 2 min, remove the disinfectant, The washed eggs are sent to the egg white and yolk separator, the egg shell, egg white and egg yolk are separated, the egg yolk is collected, weighed, and stirred at 300 r/min for 10 minutes to obtain egg yolk liquid, which is ready for use;
2、将新型零维碳基纳米材料碳点加入到浓度为0.3M,pH值5.1的乙酸-乙酸钠缓冲溶液中,制成含碳点浓度为12.5μg/mL的卵黄抗体提取缓冲液;2. Add the new zero-dimensional carbon-based nanomaterial carbon dots into the acetic acid-sodium acetate buffer solution with a concentration of 0.3M and a pH value of 5.1 to prepare a yolk antibody extraction buffer containing carbon dots with a concentration of 12.5 μg/mL;
3、按质量体积比为1:5的比例在卵黄液中加入卵黄抗体提取缓冲液,400r/min搅拌10min,室温静置沉淀9h;用真空泵吸取上清至的洁净容器,沉淀再12000r/min离心20min取上清,合并上清液即得到卵黄抗体提取液。3. Add egg yolk antibody extraction buffer to the egg yolk solution at a ratio of 1:5 by mass to volume, stir at 400 r/min for 10 minutes, and let stand for 9 hours at room temperature for precipitation; use a vacuum pump to suck the supernatant into a clean container, and then precipitate at 12,000 r/min. Centrifuge for 20 min to take the supernatant, and combine the supernatant to obtain the egg yolk antibody extract.
实施例5Example 5
抗大菱鲆IL-1β卵黄抗体的提取Extraction of Anti-Turbot IL-1β Egg Yolk Antibody
1、抗大菱鲆IL-1β高免蛋用常温自来水清洗1min,用0.25mg/L的二氧化氯水溶液消毒洗净的鸡蛋2min;再用自来水喷淋消毒过的鸡蛋2min,去除消毒液,将洗净的鸡蛋送入蛋清蛋黄分离机,分离蛋壳、蛋清及蛋黄,收集卵黄,称重,400r/min搅拌10min,得卵黄液,待用;1. The high-immunity eggs against turbot IL-1β were washed with tap water at room temperature for 1 min, and the washed eggs were disinfected with 0.25mg/L chlorine dioxide aqueous solution for 2 min; then the sterilized eggs were sprayed with tap water for 2 min to remove the disinfectant, The washed eggs are sent to the egg white and yolk separator, the egg shell, egg white and egg yolk are separated, the egg yolk is collected, weighed, and stirred at 400 r/min for 10 minutes to obtain egg yolk liquid, which is ready for use;
2、将新型零维碳基纳米材料碳点加入到浓度为0.2M,pH值5.1的乙酸-乙酸钠缓冲溶液中,制成含碳点浓度为12.5μg/mL的卵黄抗体提取缓冲液;2. Add the new zero-dimensional carbon-based nanomaterial carbon dots into an acetic acid-sodium acetate buffer solution with a concentration of 0.2M and a pH value of 5.1 to prepare a yolk antibody extraction buffer containing carbon dots with a concentration of 12.5 μg/mL;
3、按质量体积比为1:7的比例在卵黄液中加入卵黄抗体提取缓冲液,300r/min搅拌10min,室温静置沉淀10h;用真空泵吸取上清至的洁净容器,沉淀再9000r/min离心30min取上清,合并上清液即得到卵黄抗体提取液。3. Add egg yolk antibody extraction buffer to egg yolk solution at a ratio of 1:7 by mass to volume, stir at 300 r/min for 10 min, and let stand for 10 h at room temperature; suck the supernatant into a clean container with a vacuum pump, and precipitate at 9000 r/min. Centrifuge for 30 min to take the supernatant, and combine the supernatant to obtain the egg yolk antibody extract.
实施例6Example 6
抗大菱鲆IL-1β卵黄抗体的提取Extraction of Anti-Turbot IL-1β Egg Yolk Antibody
1、抗大菱鲆IL-1β高免蛋用常温自来水清洗1min,用0.25mg/L的二氧化氯水溶液消毒洗净的鸡蛋2min;再用自来水喷淋消毒过的鸡蛋2min,去除消毒液,将洗净的鸡蛋送入蛋清蛋黄分离机,分离蛋壳、蛋清及蛋黄,收集卵黄,称重,400r/min搅拌10min,得卵黄液,待用;1. The high-immunity eggs against turbot IL-1β were washed with tap water at room temperature for 1 min, and the washed eggs were disinfected with 0.25mg/L chlorine dioxide aqueous solution for 2 min; then the sterilized eggs were sprayed with tap water for 2 min to remove the disinfectant, The washed eggs are sent to the egg white and yolk separator, the egg shell, egg white and egg yolk are separated, the egg yolk is collected, weighed, and stirred at 400 r/min for 10 minutes to obtain egg yolk liquid, which is ready for use;
2、将新型零维碳基纳米材料碳点加入到浓度为0.3M,pH值5.1的乙酸-乙酸钠缓冲溶液中,制成含碳点浓度为12.5μg/mL的卵黄抗体提取缓冲液;2. Add the new zero-dimensional carbon-based nanomaterial carbon dots into the acetic acid-sodium acetate buffer solution with a concentration of 0.3M and a pH value of 5.1 to prepare a yolk antibody extraction buffer containing carbon dots with a concentration of 12.5 μg/mL;
3、按质量体积比为1:9的比例在卵黄液中加入卵黄抗体提取缓冲液,200r/min搅拌30min,室温静置沉淀15h;用真空泵吸取上清至的洁净容器,沉淀再4000r/min离心30min取上清,合并上清液即得到卵黄抗体提取液。3. Add egg yolk antibody extraction buffer to the egg yolk solution at a ratio of 1:9 by mass to volume, stir at 200 r/min for 30 minutes, and let it stand for 15 hours at room temperature for precipitation; suck the supernatant into a clean container with a vacuum pump, and then precipitate at 4000 r/min. Centrifuge for 30 min to take the supernatant, and combine the supernatant to obtain the egg yolk antibody extract.
实施例7Example 7
抗大菱鲆IL-1β卵黄抗体的提取Extraction of Anti-Turbot IL-1β Egg Yolk Antibody
1、抗大菱鲆IL-1β高免蛋用常温自来水清洗1min,用0.25mg/L的二氧化氯水溶液消毒洗净的鸡蛋2min;再用自来水喷淋消毒过的鸡蛋2min,去除消毒液,将洗净的鸡蛋送入蛋清蛋黄分离机,分离蛋壳、蛋清及蛋黄,收集卵黄,称重,200r/min搅拌15min,得卵黄液,待用;1. The high-immunity eggs against turbot IL-1β were washed with tap water at room temperature for 1 min, and the washed eggs were disinfected with 0.25mg/L chlorine dioxide aqueous solution for 2 min; then the sterilized eggs were sprayed with tap water for 2 min to remove the disinfectant, The washed eggs are sent to the egg white and yolk separator, the egg shell, egg white and egg yolk are separated, the egg yolk is collected, weighed, and stirred at 200 r/min for 15 minutes to obtain egg yolk liquid, which is ready for use;
2、将新型零维碳基纳米材料碳点加入到浓度为0.1M,pH值5.1的乙酸-乙酸钠缓冲溶液中,制成含碳点浓度为25μg/mL的卵黄抗体提取缓冲液;2. Add the new zero-dimensional carbon-based nanomaterial carbon dots into an acetic acid-sodium acetate buffer solution with a concentration of 0.1 M and a pH value of 5.1 to prepare a yolk antibody extraction buffer containing carbon dots with a concentration of 25 μg/mL;
3、按质量体积比为1:5的比例在卵黄液中加入卵黄抗体提取缓冲液,400r/min搅拌10min,室温静置沉淀12h;用真空泵吸取上清至的洁净容器,沉淀再12000r/min离心20min取上清,合并上清液即得到卵黄抗体提取液。3. Add egg yolk antibody extraction buffer to egg yolk solution at a ratio of 1:5 by mass to volume, stir at 400 r/min for 10 min, and let stand for 12 h at room temperature for precipitation; suck the supernatant into a clean container with a vacuum pump, and precipitate at 12000 r/min. Centrifuge for 20 min to take the supernatant, and combine the supernatant to obtain the egg yolk antibody extract.
实施例8Example 8
抗大菱鲆IL-1β卵黄抗体的提取Extraction of Anti-Turbot IL-1β Egg Yolk Antibody
1、抗大菱鲆IL-1β高免蛋用常温自来水清洗1min,用0.25mg/L的二氧化氯水溶液消毒洗净的鸡蛋1min;再用自来水喷淋消毒过的鸡蛋2min,去除消毒液,将洗净的鸡蛋送入蛋清蛋黄分离机,分离蛋壳、蛋清及蛋黄,收集卵黄,称重,100r/min搅拌20min,得卵黄液,待用;1. Anti-Turbot IL-1β high-immunity eggs were washed with tap water at room temperature for 1 min, and the washed eggs were disinfected with 0.25mg/L chlorine dioxide aqueous solution for 1 min; then spray the sterilized eggs with tap water for 2 min, remove the disinfectant, The washed eggs are sent to the egg white and yolk separator, the egg shell, egg white and egg yolk are separated, the egg yolk is collected, weighed, and stirred at 100 r/min for 20 minutes to obtain egg yolk liquid, which is ready for use;
2、将新型零维碳基纳米材料碳点加入到浓度为0.2M,pH值5.1的乙酸-乙酸钠缓冲溶液中,制成含碳点浓度为25μg/mL的卵黄抗体提取缓冲液;2. Add the new zero-dimensional carbon-based nanomaterial carbon dots into the acetic acid-sodium acetate buffer solution with a concentration of 0.2M and a pH value of 5.1 to prepare a yolk antibody extraction buffer containing carbon dots with a concentration of 25 μg/mL;
3、按质量体积比为1:7的比例在卵黄液中加入卵黄抗体提取缓冲液,300r/min搅拌30min,室温静置沉淀10h;用真空泵吸取上清至的洁净容器,沉淀再7000r/min离心30min取上清,合并上清液即得到卵黄抗体提取液。3. Add egg yolk antibody extraction buffer to egg yolk solution at a ratio of 1:7 by mass to volume, stir at 300 r/min for 30 minutes, and let stand for 10 hours at room temperature for precipitation; suck the supernatant into a clean container with a vacuum pump, and precipitate at 7000 r/min. Centrifuge for 30 min to take the supernatant, and combine the supernatant to obtain the egg yolk antibody extract.
实施例9Example 9
抗大菱鲆IL-1β卵黄抗体的提取Extraction of Anti-Turbot IL-1β Egg Yolk Antibody
1、抗大菱鲆IL-1β高免蛋用常温自来水清洗1min,用0.25mg/L的二氧化氯水溶液消毒洗净的鸡蛋1min;再用自来水喷淋消毒过的鸡蛋2min,去除消毒液,将洗净的鸡蛋送入蛋清蛋黄分离机,分离蛋壳、蛋清及蛋黄,收集卵黄,称重,300r/min搅拌10min,得卵黄液,待用;1. Anti-Turbot IL-1β high-immunity eggs were washed with tap water at room temperature for 1 min, and the washed eggs were disinfected with 0.25mg/L chlorine dioxide aqueous solution for 1 min; then spray the sterilized eggs with tap water for 2 min, remove the disinfectant, The washed eggs are sent to the egg white and yolk separator, the egg shell, egg white and egg yolk are separated, the egg yolk is collected, weighed, and stirred at 300 r/min for 10 minutes to obtain egg yolk liquid, which is ready for use;
2、将新型零维碳基纳米材料碳点加入到浓度为0.3M,pH值5.1的乙酸-乙酸钠缓冲溶液中,制成含碳点浓度为25μg/mL的卵黄抗体提取缓冲液;2. Add the new zero-dimensional carbon-based nanomaterial carbon dots into the acetic acid-sodium acetate buffer solution with a concentration of 0.3M and a pH value of 5.1 to prepare a yolk antibody extraction buffer containing carbon dots with a concentration of 25 μg/mL;
3、按质量体积比为1:9的比例在卵黄液中加入卵黄抗体提取缓冲液,300r/min搅拌15min,室温静置沉淀15h;用真空泵吸取上清至的洁净容器,沉淀再6000r/min离心20min取上清,合并上清液即得到卵黄抗体提取液。3. Add egg yolk antibody extraction buffer to the egg yolk solution at a ratio of 1:9 by mass to volume, stir at 300 r/min for 15 minutes, and let it stand for 15 hours at room temperature for precipitation; suck the supernatant into a clean container with a vacuum pump, and precipitate at 6000 r/min. Centrifuge for 20 min to take the supernatant, and combine the supernatant to obtain the egg yolk antibody extract.
实施例10Example 10
抗鲫鱼鳃出血病病毒(CyHV-2)卵黄抗体的提取Extraction of yolk antibody against crucian carp gill hemorrhage virus (CyHV-2)
1、抗鲫鱼鳃出血病病毒(CyHV-2)高免蛋用常温自来水清洗1min,用0.25mg/L的二氧化氯水溶液消毒洗净的鸡蛋2min;再用自来水喷淋消毒过的鸡蛋2min,去除消毒液,将洗净的鸡蛋送入蛋清蛋黄分离机,分离蛋壳、蛋清及蛋黄,收集卵黄,称重,200r/min搅拌15min,得卵黄液,待用;1. The high-immunity eggs against crucian carp gill hemorrhage virus (CyHV-2) were washed with tap water at room temperature for 1 min, and the washed eggs were sterilized with 0.25mg/L chlorine dioxide aqueous solution for 2 min; and then sprayed with tap water for 2 min. Remove the disinfectant, send the washed eggs to the egg white and yolk separator, separate the egg shell, egg white and egg yolk, collect the yolk, weigh, stir at 200 r/min for 15 minutes, and obtain egg yolk liquid, which is ready for use;
2、将新型零维碳基纳米材料碳点加入到浓度为0.1M,pH值5.1的乙酸-乙酸钠缓冲溶液中,制成含碳点浓度为6.25μg/mL的卵黄抗体提取缓冲液;2. Add the new zero-dimensional carbon-based nanomaterial carbon dots into the acetic acid-sodium acetate buffer solution with a concentration of 0.1M and a pH value of 5.1 to prepare a yolk antibody extraction buffer containing carbon dots with a concentration of 6.25 μg/mL;
3、按质量体积比为1:9的比例在卵黄液中加入卵黄抗体提取缓冲液,400r/min搅拌10min,室温静置沉淀12h;用真空泵吸取上清至的洁净容器,沉淀再5000r/min离心30min取上清,合并上清液即得到卵黄抗体提取液。3. Add egg yolk antibody extraction buffer to the egg yolk solution at a ratio of 1:9 by mass to volume, stir at 400 r/min for 10 minutes, and let stand for 12 hours at room temperature for precipitation; suck the supernatant into a clean container with a vacuum pump, and precipitate at 5000 r/min. Centrifuge for 30 min to take the supernatant, and combine the supernatant to obtain the egg yolk antibody extract.
实施例11Example 11
抗鲫鱼鳃出血病病毒(CyHV-2)卵黄抗体的提取Extraction of yolk antibody against crucian carp gill hemorrhage virus (CyHV-2)
1、抗鲫鱼鳃出血病病毒(CyHV-2)高免蛋用常温自来水清洗1min,用0.25mg/L的二氧化氯水溶液消毒洗净的鸡蛋1min;再用自来水喷淋消毒过的鸡蛋2min,去除消毒液,将洗净的鸡蛋送入蛋清蛋黄分离机,分离蛋壳、蛋清及蛋黄,收集卵黄,称重,100r/min搅拌20min,得卵黄液,待用;1. The high-immunity eggs against crucian carp gill hemorrhage virus (CyHV-2) were washed with tap water at room temperature for 1 min, and the washed eggs were disinfected with 0.25mg/L chlorine dioxide aqueous solution for 1 min; and then sprayed with tap water for 2 min. Remove the disinfectant, send the washed eggs to the egg white and yolk separator, separate the egg shell, egg white and egg yolk, collect the yolk, weigh, stir at 100 r/min for 20 minutes, and obtain egg yolk liquid, which is ready for use;
2、将新型零维碳基纳米材料碳点加入到浓度为0.1M,pH值5.1的乙酸-乙酸钠缓冲溶液中,制成含碳点浓度为12.5μg/mL的卵黄抗体提取缓冲液;2. Add the new zero-dimensional carbon-based nanomaterial carbon dots into the acetic acid-sodium acetate buffer solution with a concentration of 0.1M and a pH value of 5.1 to prepare a yolk antibody extraction buffer containing carbon dots with a concentration of 12.5 μg/mL;
3、按质量体积比为1:9的比例在卵黄液中加入卵黄抗体提取缓冲液,300r/min搅拌30min,室温静置沉淀12h;用真空泵吸取上清至的洁净容器,沉淀再6000r/min离心30min取上清,合并上清液即得到卵黄抗体提取液。3. Add egg yolk antibody extraction buffer to the egg yolk solution at a ratio of 1:9 by mass to volume, stir at 300 r/min for 30 minutes, and let stand for 12 hours at room temperature for precipitation; suck the supernatant into a clean container with a vacuum pump, and precipitate at 6000 r/min. Centrifuge for 30 min to take the supernatant, and combine the supernatant to obtain the egg yolk antibody extract.
实施例12Example 12
抗鲫鱼鳃出血病病毒(CyHV-2)卵黄抗体的提取Extraction of yolk antibody against crucian carp gill hemorrhage virus (CyHV-2)
1、抗鲫鱼鳃出血病病毒(CyHV-2)高免蛋用常温自来水清洗1min,用0.25mg/L的二氧化氯水溶液消毒洗净的鸡蛋2min;再用自来水喷淋消毒过的鸡蛋2min,去除消毒液,将洗净的鸡蛋送入蛋清蛋黄分离机,分离蛋壳、蛋清及蛋黄,收集卵黄,称重,300r/min搅拌10min,得卵黄液,待用;1. The high-immunity eggs against crucian carp gill hemorrhage virus (CyHV-2) were washed with tap water at room temperature for 1 min, and the washed eggs were sterilized with 0.25mg/L chlorine dioxide aqueous solution for 2 min; and then sprayed with tap water for 2 min. Remove the disinfectant, send the washed eggs into the egg white and yolk separator, separate the egg shell, egg white and egg yolk, collect the yolk, weigh, stir at 300 r/min for 10 minutes, and obtain egg yolk liquid, which is ready for use;
2、将新型零维碳基纳米材料碳点加入到浓度为0.1M,pH值5.1的乙酸-乙酸钠缓冲溶液中,制成含碳点浓度为25μg/mL的卵黄抗体提取缓冲液;2. Add the new zero-dimensional carbon-based nanomaterial carbon dots into an acetic acid-sodium acetate buffer solution with a concentration of 0.1 M and a pH value of 5.1 to prepare a yolk antibody extraction buffer containing carbon dots with a concentration of 25 μg/mL;
3、按质量体积比为1:9的比例在卵黄液中加入卵黄抗体提取缓冲液,300r/min搅拌15min,室温静置沉淀15h;用真空泵吸取上清至的洁净容器,沉淀再7000r/min离心25min取上清,合并上清液即得到卵黄抗体提取液。3. Add egg yolk antibody extraction buffer to the egg yolk solution at a ratio of 1:9 by mass to volume, stir at 300 r/min for 15 minutes, and let it stand for 15 hours at room temperature for precipitation; suck the supernatant into a clean container with a vacuum pump, and then precipitate at 7000 r/min. Centrifuge for 25 min to take the supernatant, and combine the supernatant to obtain the egg yolk antibody extract.
上述各实施例中,碳点制备方法为:将维生素C通过一步法电化学方法制备所得的尺寸在50nm以下的零维碳基纳米材料。将不同浓度的零维碳基纳米碳点添加到纯化的IgY蛋白溶液,通过圆二色谱分析不同浓度碳点对IgY蛋白结构的影响,发现当碳点浓度低于25μg/mL时IgY的蛋白质结构及稳定性基本无影响,当碳点浓度达到50μg/mL时在190-210nm之间的峰高稍有下降,IgY二级结构的稳定性略偏低(见图1)。因此25μg/mL以下的低浓度纳米碳点可用于提取卵黄抗体。In the above embodiments, the carbon dots are prepared as follows: a zero-dimensional carbon-based nanomaterial with a size of less than 50 nm is prepared from vitamin C by a one-step electrochemical method. Different concentrations of zero-dimensional carbon-based nano-carbon dots were added to the purified IgY protein solution, and the effect of different concentrations of carbon dots on the structure of IgY protein was analyzed by circular dichroism. When the concentration of carbon dots reaches 50 μg/mL, the peak height between 190-210 nm decreases slightly, and the stability of the secondary structure of IgY is slightly lower (see Figure 1). Therefore, low concentrations of carbon nanodots below 25 μg/mL can be used to extract egg yolk antibodies.
二、结果分析2. Analysis of the results
1、抗大菱鲆IL-1β卵黄抗体粗提液蛋白含量的测定。采用BCA蛋白浓度测定试剂盒测定(购自北京索莱宝生物科技有限公司)卵黄抗体提取液中水溶性蛋白含量,结果见表1。1. Determination of protein content in crude extract of anti-Turbot IL-1β yolk antibody. The BCA protein concentration assay kit was used to measure the water-soluble protein content in the egg yolk antibody extract (purchased from Beijing Solaibao Biotechnology Co., Ltd.), and the results are shown in Table 1.
表1不同浓度碳点及不同比例的缓冲液提取卵黄中水溶性蛋白的效率(mg/g卵黄)Table 1 Efficiency (mg/g egg yolk) of extracting water-soluble protein from egg yolk with different concentrations of carbon dots and different proportions of buffers
注:所有数据肩标字母不同者表示差异显著(P<0.05)。Note: All data with different shoulder letters indicate significant difference (P<0.05).
由表1可知,各试验组卵黄抗体提取液中水溶性蛋白浓度随碳点浓度的提高而提高。综合比较,当碳点浓度为25μg/mL时,缓冲液比例为1:9组的卵黄抗体提取效果最好,达到极显著性差异(P<0.01),其次是缓冲液比例为1:7组(P<0.05);当碳点浓度为12.5μg/mL,缓冲液比例为1:9时,蛋白提取效率同样达到显著水平(P<0.05)。说明碳点的添加有助于水溶性蛋白的提取。It can be seen from Table 1 that the concentration of water-soluble protein in the yolk antibody extract of each test group increased with the increase of the concentration of carbon dots. Comprehensive comparison, when the concentration of carbon dots was 25μg/mL, the egg yolk antibody extraction effect was the best in the buffer ratio of 1:9 group, with a very significant difference (P<0.01), followed by the buffer ratio of 1:7 group (P<0.05); when the carbon dot concentration was 12.5 μg/mL and the buffer ratio was 1:9, the protein extraction efficiency also reached a significant level (P<0.05). It shows that the addition of carbon dots is helpful for the extraction of water-soluble proteins.
2、抗大菱鲆IL-1β卵黄抗体粗提液中IgY量的直观测定。因卵黄抗体提取液中存在一定量的杂蛋白,为进一步直观检测抗大菱鲆IL-1β卵黄抗体提取液中IgY的提取效果,本发明将卵黄抗体提取液用质量体积比为19%的硫酸铵溶液(国药集团,AR级,CAS:7783-20-2)进行沉淀后,用卵黄抗体提取液相同体积的PBS(0.1M,pH 7.2)缓冲液重悬,然后SDS-PAGE电泳,鉴定抗体提取效果,结果见图2。其中M:蛋白Marker,泳道1-3:分别为碳点浓度为0μg/mL,泳道4-6(实施例1-3):分别为碳点浓度为6.25μg/mL,泳道7-9(实施例4-6):分别为碳点浓度为12.5μg/mL,泳道10-12(实施例7-9):分别为碳点浓度为25μg/mL;泳道1、4、7、10的卵黄与缓冲液质量体积比为1:5,泳道2、5、8、11的卵黄与缓冲液质量体积比为1:7,泳道3、6、9、12的卵黄与缓冲液质量体积比为1:9。2. Visual determination of the amount of IgY in the crude extract of anti-Turbot IL-1β yolk antibody. Because there is a certain amount of impurity protein in the egg yolk antibody extract, in order to further visually detect the extraction effect of IgY in the anti-Turbot IL-1β egg yolk antibody extract, the present invention uses the egg yolk antibody extract with a mass-volume ratio of 19% sulfuric acid. After precipitation with ammonium solution (Sinopharm Group, AR grade, CAS: 7783-20-2), resuspend with the same volume of PBS (0.1M, pH 7.2) buffer of egg yolk antibody extract, and then SDS-PAGE electrophoresis to identify the antibody The extraction effect, the results are shown in Figure 2. Wherein M: Protein Marker, lanes 1-3: the concentration of carbon dots is 0 μg/mL, lanes 4-6 (Example 1-3): the concentration of carbon dots is 6.25 μg/mL, respectively, lanes 7-9 (implementation Example 4-6): the concentration of carbon dots is 12.5 μg/mL, respectively, lane 10-12 (Example 7-9): the concentration of carbon dots is 25 μg/mL; the yolk and The mass-volume ratio of buffer solution is 1:5, the mass-volume ratio of egg yolk to buffer solution in
由图2可知,卵黄抗体SDS-PAGE电泳图可观察到66kDa左右的IgY重链、25kDa左右的IgY轻链,以及40kDa上下的两条杂蛋白条带。从抗体纯度(即条带灰度)分析,相同缓冲溶液比例组,当碳点浓度为6.25μg/mL时抗体提取效果最好,其次为12.5μg/mL浓度组,其它组差异不明显。此结果与卵黄抗体提取液中水溶性蛋白含量结果不一致,说明高浓度碳点在提取卵黄抗体的同时提高了部分非卵黄抗体的水溶性杂蛋白,低浓度碳点更有利于卵黄抗体IgY的提取。It can be seen from Figure 2 that the yolk antibody SDS-PAGE electrophoresis can observe the IgY heavy chain of about 66kDa, the IgY light chain of about 25kDa, and two heteroprotein bands above and below 40kDa. From the analysis of antibody purity (i.e., the gray scale of the bands), the antibody extraction effect was the best in the same buffer solution ratio group when the carbon dot concentration was 6.25 μg/mL, followed by the 12.5 μg/mL concentration group, and the difference between the other groups was not obvious. This result is inconsistent with the results of water-soluble protein content in egg yolk antibody extract, indicating that high concentration of carbon dots can improve the water-soluble impurity protein of some non-yolk antibody while extracting egg yolk antibody, and low concentration of carbon dots is more conducive to the extraction of egg yolk antibody IgY .
3、抗大菱鲆IL-1β卵黄抗体及抗鲫鱼鳃出血病病毒(CyHV-2)卵黄抗体粗提液中IgY效价的测定。卵黄抗体提取液中抗体效价采用间接ELISA法测定,即分别大菱鲆IL-1β重组蛋白、鲫鱼鳃出血病病毒CyHV-2(ORF72、ORF66、ORF81、ORF82串联基因,即CyHV-2-D4ORF)的重组蛋白为包被抗原,分别以不同稀释度的抗大菱鲆IL-1β、抗CyHV-2-D4ORF的卵黄抗体提取液为一抗,以1:2000稀释的HRP羊抗鸡IgY为二抗进行抗体效价的检测,阴性对照是相同条件提取的普通鸡蛋中的卵黄抗体,空白对照为PBS。判定标准为:P/N=(待测OD值-空白对照OD值)/(阴性对照OD值-空白对照OD值),当P/N≥2.1时抗体最大稀释度即为抗体效价。结果分别见图3及图4。3. Determination of IgY titer in crude extract of anti-Turbot IL-1β yolk antibody and anti-Crucian carp gill hemorrhage virus (CyHV-2) yolk antibody. The antibody titer in the egg yolk antibody extract was determined by indirect ELISA, namely, the recombinant protein of turbot IL-1β, the tandem gene of carp gill hemorrhage virus CyHV-2 (ORF72, ORF66, ORF81, ORF82, namely CyHV-2-D4ORF) The recombinant protein of ) is the coating antigen, and the egg yolk antibody extract of anti-Turbot IL-1β and anti-CyHV-2-D4ORF of different dilutions is used as the primary antibody, and the HRP goat anti-chicken IgY diluted at 1:2000 is used as the primary antibody. The secondary antibody was used to detect the antibody titer. The negative control was egg yolk antibody extracted from common eggs under the same conditions, and the blank control was PBS. The judgment standard is: P/N=(OD value to be measured - OD value of blank control)/(OD value of negative control - OD value of blank control), when P/N≥2.1, the maximum dilution of the antibody is the antibody titer. The results are shown in Figure 3 and Figure 4, respectively.
由图3中ELISA结果可知,当卵黄与缓冲溶液比例为1:5时,乙酸-乙酸钠缓冲溶液中添加碳点后各组卵黄抗体提取液中抗体效价均由对照组的1:16000提高到了1:32000;当卵黄与缓冲溶液比例为1:7时,碳点浓度6.25μg/mL及12.5μg/mL组的抗体效价由1:16000提高到了1:32000,但碳点浓度25μg/mL组的抗体效价与未添加碳点组无差异;当卵黄与缓冲溶液比例为1:9时,对照组抗体效价为1:8000,碳点浓度25μg/mL组的抗体效价为1:16000,而碳点浓度6.25μg/mL及12.5μg/mL组的抗体效价达到了1:32000。此结果一方面说明碳点的添加有助于IgY的提取,另一方面说明低浓度碳点提取IgY的效果较好。It can be seen from the ELISA results in Figure 3 that when the ratio of egg yolk to buffer solution is 1:5, the antibody titers in the egg yolk antibody extracts of each group are increased by 1:16000 of the control group after adding carbon dots to the acetic acid-sodium acetate buffer solution. When the ratio of yolk and buffer solution was 1:7, the antibody titer of the Cdot concentration 6.25μg/mL and 12.5μg/mL groups increased from 1:16000 to 1:32000, but the Cdot concentration was 25μg/mL. The antibody titer of the mL group was not different from that of the non-carbon dots group; when the ratio of egg yolk to buffer solution was 1:9, the antibody titer of the control group was 1:8000, and the antibody titer of the carbon dot concentration 25μg/mL group was 1 : 16000, and the antibody titer of the C-dot concentration 6.25μg/mL and 12.5μg/mL groups reached 1:32000. On the one hand, this result shows that the addition of carbon dots is helpful for the extraction of IgY, and on the other hand, it shows that the effect of low concentration carbon dots to extract IgY is better.
抗鲫鱼鳃出血病病毒(CyHV-2-D4ORF)卵黄抗体提取液中抗体效价采用ELISA法测定,结果见图4。当卵黄与缓冲液比例为1:9时,对照组抗体效价为1:8000,碳点浓度6.25μg/mL组、12.5μg/mL组和25μg/mL组抗体效价分别为1:16000、1:16000和1:8000。此结果进一步验证了低浓度碳点提取IgY的效果最好,效价明显提高。Antibody titers in the yolk antibody extract against crucian carp gill hemorrhage virus (CyHV-2-D4ORF) were determined by ELISA, and the results are shown in Figure 4. When the ratio of egg yolk to buffer was 1:9, the antibody titer of the control group was 1:8000, and the antibody titers of the 6.25μg/mL, 12.5μg/mL and 25μg/mL groups were 1:16000, 1:16000 and 1:8000. This result further verifies that low-concentration carbon dots have the best extraction effect of IgY, and the titer is significantly improved.
4、抗鲫鱼鳃出血病病毒(CyHV-2)卵黄抗体粗提液中细菌含量测定。用LB固体平板涂布,测定不同浓度的碳点处理的抗鲫鱼鳃出血病病毒(CyHV-2)卵黄抗体提取液中总菌含量(实施例10-12)。卵黄抗体提取液与卵黄中原有脂肪沉淀混合后,分别取100μL涂布,培养24h后统计菌落数。4. Determination of bacterial content in crude extract of yolk antibody against crucian carp gill hemorrhage virus (CyHV-2). Coat with LB solid plate, and measure the total bacterial content in the yolk antibody extract of anti-Crucian carp gill hemorrhage virus (CyHV-2) treated with different concentrations of carbon dots (Examples 10-12). After mixing the egg yolk antibody extract with the original fat precipitate in the egg yolk, 100 μL were taken and coated, and the number of colonies was counted after culturing for 24 hours.
用LB固体平板涂布法测定不同浓度的碳点对抗鲫鱼鳃出血病病毒(CyHV-2-D4ORF)卵黄抗体提取液中总菌含量的影响,以及处理参数相同时室温与4℃条件下静置沉淀15h菌含量的差异。结果见图5。结果表明:其他参数相同时室温比4℃提取的抗体液中菌含量高;当缓冲液中加入碳点后卵黄抗体提取液中的细菌含量显著下降(P<0.05),且菌落数随碳点浓度的提高而减少,直至完全抑制细菌生长。说明在添加一定浓度碳点的情况下,可以实现室温提取卵黄抗体,且因碳点会降解而无毒,使得提取卵黄抗体后的副产品可进一步开发利用。因此加入纳米材料后可将工艺参数从4℃改为室温,简单方便。提高利用率。LB solid plate coating method was used to determine the effect of different concentrations of carbon dots on the content of total bacteria in the yolk antibody extract against crucian carp gill hemorrhage virus (CyHV-2-D4ORF), and the treatment parameters were the same at room temperature and 4 ℃. The difference of bacterial content in 15h precipitation. The results are shown in Figure 5. The results showed that when other parameters were the same, the bacterial content in the antibody solution extracted at room temperature was higher than that in 4 ℃; when the Cdots were added to the buffer, the bacterial content in the egg yolk antibody extraction solution decreased significantly (P<0.05), and the number of colonies increased with the Cdots. The concentration increases and decreases until bacterial growth is completely inhibited. It is indicated that under the condition of adding a certain concentration of carbon dots, egg yolk antibody can be extracted at room temperature, and the carbon dots will be degraded and non-toxic, so that the by-products after extraction of egg yolk antibody can be further developed and utilized. Therefore, the process parameters can be changed from 4°C to room temperature after adding nanomaterials, which is simple and convenient. increase profit.
结论:综合考评不同浓度碳点及不同比例的缓冲溶液对卵黄抗体提取效果的影响,本发明最终确定当碳点浓度为6.25μg/mL~12.5μg/mL,卵黄液与缓冲溶液比例为1:5~1:9均可达到较好的提取效果。进一步地,当需要高浓度抗体时,可通过其它技术方法将抗体进一步浓缩。Conclusion: After comprehensively evaluating the effects of different concentrations of carbon dots and buffer solutions of different proportions on the extraction effect of egg yolk antibody, the present invention finally determines that when the concentration of carbon dots is 6.25 μg/mL ~ 12.5 μg/mL, the ratio of egg yolk solution to buffer solution is 1: 5~1:9 can achieve better extraction effect. Further, when a high concentration of antibody is required, the antibody can be further concentrated by other technical methods.
上述说明并非对本发明的限制,本发明也并不限于上述举例。本技术领域的普通技术人员在本发明的实质范围内,做出的变化、改型、添加或替换,也应属于本发明的保护范围。The above description does not limit the present invention, and the present invention is not limited to the above examples. Changes, modifications, additions or substitutions made by those skilled in the art within the essential scope of the present invention should also belong to the protection scope of the present invention.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011203157.6A CN112142839B (en) | 2020-11-02 | 2020-11-02 | Method suitable for extracting yolk antibody in industrialized large scale |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011203157.6A CN112142839B (en) | 2020-11-02 | 2020-11-02 | Method suitable for extracting yolk antibody in industrialized large scale |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112142839A true CN112142839A (en) | 2020-12-29 |
CN112142839B CN112142839B (en) | 2022-01-18 |
Family
ID=73955162
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011203157.6A Active CN112142839B (en) | 2020-11-02 | 2020-11-02 | Method suitable for extracting yolk antibody in industrialized large scale |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112142839B (en) |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4550019A (en) * | 1978-03-22 | 1985-10-29 | South Africa Inventions Development Corporation | Manufacture and use of fowl egg antibodies |
KR20020057464A (en) * | 2001-01-05 | 2002-07-11 | 이남형 | Method for Separation and Refinement of water soluble protein and lipoprotein in egg yolk with IgY |
CN101955532A (en) * | 2010-10-21 | 2011-01-26 | 郑州后羿制药有限公司 | Method for extracting chicken egg yolk antibodies against infectious bursal disease |
EP2482836A1 (en) * | 2009-10-02 | 2012-08-08 | Oslo Universitetssykehus HF | Antibacterial polypeptides and use thereof |
CN103509106A (en) * | 2013-10-08 | 2014-01-15 | 河南科技学院 | Method for extracting chicken egg-yolk antibody |
CN106810607A (en) * | 2015-12-02 | 2017-06-09 | 天津振邦水产养殖有限公司 | A kind of high-titer Yolk antibody preparation method |
US20180036225A1 (en) * | 2013-10-25 | 2018-02-08 | R.F. Technology Consultants, Inc. | Compositions And Methods Comprising Yeast Organisms And Lipid Extracts Thereof |
CN109432444A (en) * | 2018-11-19 | 2019-03-08 | 河南师范大学 | A kind of preparation method and its drug of the traceable anti-tumor drug based on carbon dots |
-
2020
- 2020-11-02 CN CN202011203157.6A patent/CN112142839B/en active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4550019A (en) * | 1978-03-22 | 1985-10-29 | South Africa Inventions Development Corporation | Manufacture and use of fowl egg antibodies |
KR20020057464A (en) * | 2001-01-05 | 2002-07-11 | 이남형 | Method for Separation and Refinement of water soluble protein and lipoprotein in egg yolk with IgY |
EP2482836A1 (en) * | 2009-10-02 | 2012-08-08 | Oslo Universitetssykehus HF | Antibacterial polypeptides and use thereof |
CN101955532A (en) * | 2010-10-21 | 2011-01-26 | 郑州后羿制药有限公司 | Method for extracting chicken egg yolk antibodies against infectious bursal disease |
CN103509106A (en) * | 2013-10-08 | 2014-01-15 | 河南科技学院 | Method for extracting chicken egg-yolk antibody |
US20180036225A1 (en) * | 2013-10-25 | 2018-02-08 | R.F. Technology Consultants, Inc. | Compositions And Methods Comprising Yeast Organisms And Lipid Extracts Thereof |
CN106810607A (en) * | 2015-12-02 | 2017-06-09 | 天津振邦水产养殖有限公司 | A kind of high-titer Yolk antibody preparation method |
CN109432444A (en) * | 2018-11-19 | 2019-03-08 | 河南师范大学 | A kind of preparation method and its drug of the traceable anti-tumor drug based on carbon dots |
Non-Patent Citations (5)
Title |
---|
POOJA DEVI ET AL: "The advanced role of carbon quantum dots in nanomedical applications", 《BIOSENS BIOELECTRON》 * |
RONGJIA SHI ET AL: "Fluorescence detection of histamine based on specific binding bioreceptors and carbon quantum dots", 《BIOSENS BIOELECTRON》 * |
王春来等: "碳量子点-二氧化钛复合光催化剂的研究进展", 《材料导报》 * |
赵艳: "碳量子点的抑菌性能研究", 《延安大学学报( 自然科学版)》 * |
阮志鹏等: "碳量子点抗菌活性的研究进展", 《中国微生态学杂志》 * |
Also Published As
Publication number | Publication date |
---|---|
CN112142839B (en) | 2022-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102242115B (en) | Kit for extracting bacterial plasmid DNA by paramagnetic particle method and extraction method thereof | |
CN112391384B (en) | Kit for rapidly extracting genomic DNA of gram-negative bacteria and extraction method | |
CN107118262A (en) | A kind of Mycoplasma bovis MbovP579 albumen and its application | |
WO2020093674A1 (en) | Recombinant h7n9 subtype avian influenza virus strain, inactivated labeled vaccine and preparation method therefor | |
CN116813720A (en) | Preparation method of porcine pseudorabies virus gD protein and porcine pseudorabies virus subunit vaccine and application | |
US20230193194A1 (en) | Generic inert bio-vector salmonella sp. and potential uses thereof | |
CN115850396A (en) | RSV (respiratory syncytial virus) nanoparticle vaccine as well as preparation method and application thereof | |
CN112680388A (en) | Bacillus subtilis planted in nasal cavity of pig and application of bacillus subtilis in antiviral activity | |
CN105821010B (en) | A kind of recombinant NDV expressing chicken IBDV antibody and its application in the preparation of bivalent vaccine | |
CN115746130B (en) | Duck reovirus monoclonal antibody NDRV-sigma C, detection kit and application thereof | |
CN102584957B (en) | Specific antibody of Brucella specificity multi-epitope artificial polypeptide, immunomagnetic beads coated with specific bodies, and application of beads | |
CN104292311B (en) | Antigen for detecting porcine epidemic diarrhea virus neutralizing antibody, and preparation method and application thereof | |
CN112142839A (en) | A method suitable for industrial large-scale extraction of egg yolk antibodies | |
CN102680699B (en) | ELISA detection method for identifying group I adenovirus infection in poultry | |
CN113549634B (en) | Gene for coding soluble HPV58L1 protein and construction and application of recombinant plasmid thereof | |
WO2021232800A1 (en) | Generic inert carrier escherichia coli and potential use thereof | |
CN103059122A (en) | Recombined porcine interferon alpha 1, as well as gene encoding gene and expression method thereof | |
CN102180953B (en) | Chlamydophila abortus outer membrane recombinant protein, and coding gene and application thereof | |
CN103059123B (en) | A kind of recombinant porcine interferon beta 1 and its coding gene and expression method | |
CN101921799B (en) | Preparation method of horse serum amyloid protein A1 and expression vector and genetic engineering bacteria thereof | |
CN116840463A (en) | Colloidal gold test strip for rana nigromaculata iridovirus antibody, and preparation method and application thereof | |
CN104360059A (en) | Non-diagnostic immunological detection method of machupo virus | |
CN103524624B (en) | Avian pneumo-encephalitis virus and duck circovirus fusion rotein and encoding gene thereof and application | |
CN114836390B (en) | A cold-adapted live attenuated vaccine strain of H9N2 subtype avian influenza virus MDCK cells and its application | |
CN103146715A (en) | A tandem recombinant expression method of Mycobacterium tuberculosis ESAT6 antigen protein and its application in tuberculosis detection |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |